三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

CDMO

Macromolecule Drug CDMO Platform

1.Platform Overview
 

Macromolecular platforms comply with GMP Standards of US FDA、EU EMA and NMPA of China. It equipped with 500L/2000L scale production line (designed by NEPHARM, with cGMP standards, equipped with Sartorius Bioreactor, Millipore System and GE Purification System, Bosch washing & drying & irrigation & rolling linkage line, 3M sterilization cabinet and Schneider SCADA Automation Control System).

The core personnel of the platform operation team have more than 15 years  work-experience in Internationale-leading pharmaceutical and biotechnology companies such as KANGHONG, INNOVENT and Bristol-Myers Squibb, and have rich experience in process development and scale-up, process control and quality control, project management, etc., and have experience in the marketing and R&D and production of 8 biological drugs.
 

2.Service Content

The platform can provide stable cell line screening, pilot fermentation process, large-scale culture process and macromolecular purification process development services, antibody drugs, recombinant protein drugs, protein vaccine pilot and large-scale production services and other biological macromolecular pharmaceutical preparations production technical services, support products in China, United States, Europe and other places to conduct clinical trials and rapid marketing, and achieve global synchronous transformation of customer research results.


3.Reality view
 

 

 

Small Molecule Drug CDMO Platform
 

1.Platform Overview

Zhengzhou Pioneerpharm Pharmaceutical Co., Ltd. (Small Molecule API & Preparation CDMO Platform) is an organic part of the Lifezhengzhou · Leadingpharm CXO System. It is jointly built by Leadingpharm, Beijing Chempion Biology and Lifezhengzhou Biomedical Park, provideing technical services related to small molecule industrialization and clinical sample preparation for national pharmaceutical enterprises.
The platform complies with GMP standards of FDA and NMPA, with a total construction area of 6651.54㎡. It is equipped with three preparation workshops (oral solid preparation workshop, small volume injection workshop and oral solution workshop), with supporting power center, storage, quality inspection and other institutions or facilities.

2.Service Content

The platform provides a qualified site for the production of clinical samples of innovative drugs, commercial production of rare disease drugs, pilot test and commercial production of imitation drugs. The dosage forms include tablets, capsules, granules, oral liquid, small volume injection and other conventional oral and injection dosage forms.
The platform can produce 200 million preparation units of solid preparations, 15 million preparation units of injections, 12 million preparation units of oral liquid, 60 pilot projects and 1000 batches of testing per year, enabling innovative enterprises to break through bottlenecks and grow at a high speed.

3.Reality view

 




 

 

 

 

 

日韩高清视频在线观看中字| 国产精品女上位高潮白浆| 久久人妻丝袜av中文字幕| 99re热免费视频一区| 国产99视频精品免视看9| 亚洲人成伊人成综合久久| 欧美精品亚洲精品日韩一| 亚洲国产av精品一区二| 国产精品v亚洲精品色欲| 日本亚洲欧洲中文精品专| 国产亚洲欧美成人精品久久| 東京热av精品人妻一区二区三区| 色综合久久88色综合天天| 加勒比一区二区三区高清| 69久久精品亚洲一区二区| 欧美日韩视频在线第一区| 中文字幕无码乱人伦| 亚洲精品国产av在线小说| 久久麻豆精亚洲av品国产| 日本一二三四五区日韩精品| 国产清纯美女啪精品一区| 久久精品免费一区二区三| 久久久综合精品| 插b操b后入b在线观看| 欧美另类天天天天狠狠久久| 免费av大尺度在线观看| 尤物193欧美精品一区| 国产欧美一区二区精品婷| 给我免费播放片在线| 99热这里只有精品26| a天堂精品一区二区三区| 国产一本到在线视频观看| 亚洲无码a一a二a三区| 欧美在线视频| 日韩视频一区二区三区网站| 欧美激情aaa级顶级一区| 久久99热狠狠色av蜜臀| 日韩欧美啊啊啊在线观看| 性色蜜月av一区二区三区| 一二区在线观看| 精品三级久久久久电影麻豆|